OpenAI has launched the Rosalind Academic Plan, giving academic research labs at US universities access to GPT-Rosalind, its life-sciences model, which was previously limited mainly to large companies and government partners.
Eligible labs can receive up to 30 free ChatGPT Business Standard seats for up to 12 months. Access to GPT-Rosalind itself sits behind a separate trusted-access approval, on top of the standard review every lab goes through to join the plan. OpenAI says applications are assessed for eligibility and responsible use, and that holding a university email address, or an existing OpenAI subscription, does not guarantee acceptance.
A principal investigator or lab lead applies on behalf of the group and, once approved, manages which lab members get access. Approval also involves a review of lab leadership and requires the institution to name a safety contact.
The plan does not include API access, so labs cannot wire GPT-Rosalind directly into automated pipelines through this programme; it is designed for interactive use inside ChatGPT instead. OpenAI says research data shared through the plan is not used by default to train its models.
GPT-Rosalind is normally delivered through OpenAI's Rosalind Workbench for tasks such as medicinal chemistry and genomics analysis. By extending access to universities, OpenAI is betting that academic researchers, not just commercial labs, will find valuable applications for a model built around biological and chemical research problems.
Source: OpenAI
